Changes to the Code
H.R. 4184 · To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes. · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
26 U.S.C. § 139J Clinical trial payments New section
1 change the bill asks for here, 1 carried out
- Carried out:
Part III of subchapter B of chapter 1 of the Internal Revenue Code of 1986 is amended by inserting after section 139I the following new section:139J. Clinical trial payments (a) In general.— Gross income shall not include any amount received by an individual as a qualified clinical trial payment. (b) Qualified clinical trial payment defined.— For purposes of this section, the term
qualified clinical trial payment
means any amount paid to an individual— (1) as compensation for participation by the individual or a dependent of the individual in an approved clinical trial, or (2) to reimburse or pay reasonable and necessary expenses incurred in connection with participation by the individual or a dependent of the individual in an approved clinical trial. (c) Other definitions.— For purposes of this section— (1) Approved clinical trial.— The termapproved clinical trial
has the meaning given such term in section 2709(d)(1) of the Public Health Service Act (42 U.S.C. 300gg–8(d)(1)), determined by applyingdisease or condition
forlife-threatening disease or condition
. (2) Dependent.— The termdependent
has the meaning given such term in section 152..The section already has a provision under this letter or number, so it would have two.
The Code already has a 26 U.S.C. § 139J, a different section added since this bill was written, so this would be a second section under that number.
§ 139J(a)–(c)
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| § 139J. [inserted: Clinical trial payments] | ||||
| (a) | (a) [inserted: In general.—] | |||
| [inserted: Gross income shall not include any amount received by an individual as a qualified clinical trial payment.] | ||||
| (b) | (b) [inserted: Qualified clinical trial payment defined.—] | |||
| [inserted: For purposes of this section, the term “qualified clinical trial payment” means any amount paid to an individual—] | ||||
| (b)(1) | (1) [inserted: ] | |||
| [inserted: as compensation for participation by the individual or a dependent of the individual in an approved clinical trial, or] | ||||
| (b)(2) | (2) [inserted: ] | |||
| [inserted: to reimburse or pay reasonable and necessary expenses incurred in connection with participation by the individual or a dependent of the individual in an approved clinical trial.] | ||||
| (c) | (c) [inserted: Other definitions.—] | |||
| [inserted: For purposes of this section—] | ||||
| (c)(1) | (1) [inserted: Approved clinical trial.—] | |||
| [inserted: The term “approved clinical trial” has the meaning given such term in section 2709(d)(1) of the Public Health Service Act (42 U.S.C. 300gg–8(d)(1)), determined by applying “disease or condition” for “life-threatening disease or condition”.] | ||||
| (c)(2) | (2) [inserted: Dependent.—] | |||
| [inserted: The term “dependent” has the meaning given such term in section 152.] | ||||